Biomarker Assay Validation in Healthy Smokers and COPD Smokers and Ex-smokers

NCT02490358 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2016-02-03

No results posted yet for this study

Summary

This study will collect sputum samples from healthy smokers, COPD smokers and COPD ex-smokers to analyse biomarkers of inflammation

Conditions

Sponsors & Collaborators

  • Babraham Institute Enterprise Limited

    collaborator OTHER
  • Respivert Ltd

    lead INDUSTRY

Principal Investigators

  • Ginny Norris, Dr · Respivert Ltd

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2016-01-31
Completion
2016-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02490358 on ClinicalTrials.gov